Abiopharma

🔍 Meister Keith A. (Executive)

Company: ILLUMINA, INC. (ILMN)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Sold 92,776 shares of Common Stock at $225.26 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 1,317,075.00 | transaction_form_type: 4 | Footnotes: F3, F1
• Sold 38,201 shares of Common Stock at $226.13 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 1,278,874.00 | transaction_form_type: 4 | Footnotes: F4, F1
• Sold 42 shares of Common Stock at $226.79 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 1,278,832.00 | transaction_form_type: 4 | Footnotes: F5, F1
• Sold 38,213 shares of Common Stock at $224.72 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 1,240,619.00 | transaction_form_type: 4 | Footnotes: F6, F1
• Sold 53,123 shares of Common Stock at $225.69 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 1,187,496.00 | transaction_form_type: 4 | Footnotes: F7, F1
• Sold 14,782 shares of Common Stock at $226.5 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 1,172,714.00 | transaction_form_type: 4 | Footnotes: F8, F1
• Sold 425 shares of Common Stock at $227.22 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 1,172,289.00 | transaction_form_type: 4 | Footnotes: F9, F1
• Sold 4,873 shares of Common Stock at $226.74 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: false | shares_owned_after: 1,167,416.00 | transaction_form_type: 4 | Footnotes: F10, F1
• Sold 54,309 shares of Common Stock at $227.67 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: false | shares_owned_after: 1,113,107.00 | transaction_form_type: 4 | Footnotes: F11, F1
• Sold 24,363 shares of Common Stock at $228.64 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: false | shares_owned_after: 1,088,744.00 | transaction_form_type: 4 | Footnotes: F12, F1
• Sold 16,990 shares of Common Stock at $229.72 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: false | shares_owned_after: 1,071,754.00 | transaction_form_type: 4 | Footnotes: F13, F1
• Sold 28,439 shares of Common Stock at $230.54 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: false | shares_owned_after: 1,043,315.00 | transaction_form_type: 4 | Footnotes: F14, F1
• Sold 9,405 shares of Common Stock at $231.23 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: false | shares_owned_after: 1,033,910.00 | transaction_form_type: 4 | Footnotes: F15, F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | shares_owned_after: 6,780.00

Footnotes:

• F1: These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.
• F2: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $224.77 to $225.76. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3)-(15) to this Form 4.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $225.77 to $226.75.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $226.78 to $226.80.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $224.09 to $225.08.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $225.09 to $226.08.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $226.09 to $226.95.
• F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $227.09 to $227.50.
• F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $226.04 to $227.03.
• F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $227.04 to $228.03.
• F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $228.04 to $229.03.
• F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $229.04 to $230.03.
• F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $230.04 to $231.03.
• F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $231.04 to $231.71.